SNSE (STOCKS)
Sensei Biotherapeutics, Inc. Common Stock
$8.840000
+0.020000 (+0.23%)
Prev close: $8.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Christopher W. Gerry
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11.25M
- Employees
- 15
- P/E (TTM)
- -0.41
- P/B (TTM)
- 0.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-3.62 | $-4.19 | +0.5722 | +13.65% |
|
Jun 2025 (Q2)
|
$-3.91 | $-5.71 | +1.8020 | +31.55% |
|
Mar 2025 (Q1)
|
$-5.40 | $-4.56 | -0.8441 | -18.53% |
|
Dec 2024 (Q4)
|
$-6.20 | $-5.64 | -0.5559 | -9.85% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $25.61M |
| Operating Income/Loss | -$25.61M |
| Income/Loss From Continuing Operations After Tax | -$24.14M |
| Income/Loss From Continuing Operations Before Tax | -$31.32M |
| Income Tax Expense/Benefit | -$7.19M |
| Interest Expense, Operating | $46.00K |
| Net Income/Loss | -$24.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$24.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$24.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.66 |
| Diluted Earnings Per Share | $3.66 |
| Basic Average Shares | 26,383,777 |
| Diluted Average Shares | 26,383,777 |
| Assets | $27.59M |
| Current Assets | $25.79M |
| Prepaid Expenses | $496.00K |
| Other Current Assets | $25.29M |
| Noncurrent Assets | $1.80M |
| Fixed Assets | $112.00K |
| Other Non-current Assets | $1.69M |
| Liabilities | $4.58M |
| Current Liabilities | $4.44M |
| Accounts Payable | $306.00K |
| Wages | $1.16M |
| Other Current Liabilities | $2.97M |
| Noncurrent Liabilities | $146.00K |
| Equity | $23.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $23.01M |
| Liabilities And Equity | $27.59M |
| Net Cash Flow From Operating Activities | -$22.38M |
| Net Cash Flow From Operating Activities, Continuing | -$22.38M |
| Net Cash Flow From Investing Activities | $14.54M |
| Net Cash Flow From Investing Activities, Continuing | $14.54M |
| Net Cash Flow From Financing Activities | -$728.00K |
| Net Cash Flow From Financing Activities, Continuing | -$728.00K |
| Net Cash Flow | -$8.57M |
| Net Cash Flow, Continuing | -$8.57M |
| Comprehensive Income/Loss | -$24.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$24.16M |
| Other Comprehensive Income/Loss | -$17.00K |